A Study Using Real-world Data to Examine Outcomes in Children and Adults Who Develop a Blood Clotting Disorder Called Thrombotic Microangiopathy (TMA) After Undergoing a Hematopoietic Stem Cell Transplant (HSCT).
Clinical trial NCT07732361 · COMPLETED
Trial details
- NCT number
- NCT07732361
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2025-01-22
- Primary completion
- 2026-03-31
- Enrollment
- 307
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.